Literature DB >> 12558

The absorption of acetylsalicylic acid from the stomach in relation to intragastric pH.

G Dotevall, G Ekenved.   

Abstract

A comparative study on the effect of a buffered (pH 6.5) and an unbuffered (pH 2.9) solution of acetylsalicylic acid (ASA) on gastric pH, gastric emptying, and gastric absorption of ASA was performed in 10 healthy volunteers. Gastric pH was recorded using radiotelemetry. Gastric emptying and gastric absorption was studied with an aspiration technique and phenol red as nonabsorbable marker. Administration of the unbuffered solution to the fasting subjects resulted in a gastric pH of about 2 and absorption of ASA from the stomach was found to occur. The buffered solution of ASA increased gastric pH to above 5 and gastric absorption of ASA was found to be significantly less than after the unbuffered solution. The buffered solution was emptied from the stomach more rapidly than the unbuffered one.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12558

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  The pharmacokinetics of aspirin in rats and the effect of buffer.

Authors:  C J Fu; S Melethil; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

Review 2.  Clinical pharmacokinetics of the salicylates.

Authors:  C J Needs; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

3.  Comparison of three aspirin formulations in human volunteers.

Authors:  Sean Patrick Nordt; Richard F Clark; Edward M Castillo; David A Guss
Journal:  West J Emerg Med       Date:  2011-11

4.  Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Rocco Mollace; Micaela Gliozzi; Roberta Macrì; Annamaria Tavernese; Vincenzo Musolino; Cristina Carresi; Jessica Maiuolo; Carolina Muscoli; Carlo Tomino; Giuseppe Maria Rosano; Massimo Fini; Maurizio Volterrani; Bruno Silvestrini; Vincenzo Mollace
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.